Failure of early interval debulking surgery after standard neoadjuvant chemotherapy: May bevacizumab add something? A large retrospective study
Iโm proud to have contributed, congratulations to @ErgastiR and the whole team!
https://t.co/Vvql0sYAvk
Integrating clinical-molecular data to predict #PARPi efficacy in advanced #OvarianCancer after #ICS
โ BRCA/HRD and CRS correlate with PFS
โ CRS is a surrogate of PARPi efficacy
โ Integrating BRCA/HRD, KELIM and CRS allows tailored maintenance
https://t.co/RhWoXfvpge
The memory of our beloved Prof. Scambia lives everyday in our hearts as we do everything exactly how he taught us. We will make him proud of us while he is supervising us from the sky. Thank you to our Leader ๐ค
@annafagottimd@frafanfani@ESGO_society@ESGEorg@ENYGO_official
The ESGO Council is extremely saddened to learn of the untimely death of Prof Giovanni Scambia, who was a great influence to and personal friend of many of our members. A moment of silence was held today during the Congress opening ceremony in his honour.
Prof Scambia touched the lives of countless patients, surgeons, fellows and others in the gynae oncology community.
We extend our condolences to his family and the many, many others who are mourning his passing. His memory will live on.